Table 3: Late §outcomes: Survivors vs non-survivors.
|
Variables (Adverse events) N = 11
(%) |
ECPR NON-SURVIVORS N = 10 (%) |
ECPR SURVIVORS |
P VALUE |
|
Cardiac |
9 (82) |
3 (20) |
0.03 |
|
RVN-2 |
4 (45) |
3 (30) |
|
|
(a)Arrhythmias |
3 (36) |
0 |
|
|
HTxP |
0 |
2
(20) |
|
|
Other |
2 (18) |
0 |
|
|
(b)Renal |
1 (9) |
0 |
0.9 |
|
Sepsis |
2 (18) |
2 (20) |
0.9 |
|
(c)MOF |
0 |
0 |
|
|
(d)Respiratory |
1 (9) |
1 (10) |
0.9 |
|
(e)Gastrointestinal |
1 (9) |
0 |
0.9 |
|
(f)Unplanned reoperation |
1 (9) |
4 (40) |
0.1 |
|
(g)Neurological |
1 (9) |
1 (10) |
0.9 |
a)requiring medical intervention; (b)Ultrafiltration/peritoneal
dialysis; (c)2 or more organ failure; (d)Respiratory
distress syndrome; Pulmonary hemorrhage; chronic respiratory failure; (e)Intestinal
hemorrhage or infarct requiring surgery; (f)Surgical re-intervention
(not stage II/III palliation or HTxP); (g)Intraventricular
hemorrhage grade II-IV; cerebral hemorrhage/ischemia; clinical or EEG
documented seizure-activity
♦during ECMO; §After ECMO decannulation prior to hospital discharge
§follow-up (mean interval 17.4 ± 5.1
months)
HTxP-heart transplantation; MOF-multiple
organ failure